LEADTEK Business Summary

Leadtek Research Inc. (2465.TW) is a prominent Taiwanese hardware manufacturer that generates revenue primarily through the design and distribution of high-performance computing (HPC) solutions and smart healthcare systems. The company operates through two core segments: the Computer Product Department, which focuses on NVIDIA-based graphics cards (GeForce and RTX Pro series), AI workstations, and GPU-accelerated servers; and the Smart Healthcare Department, which develops telemedicine devices and medical IoT wearables under the "amor" and "Alvital" brands. As of March 2026, Leadtek has pivoted its strategic focus toward high-end AI infrastructure and large language model (LLM) training hardware to capitalize on surging enterprise demand. In the competitive landscape, Leadtek contends with regional peers such as Amax Holding (6933.TW), Biostar Microtech (2399.TW), and Tul Corporation (6150.TPEX), maintaining a distinct market position through its long-standing Tier-1 partnership with NVIDIA and its specialized expansion into certified medical-grade diagnostic equipment. The company was founded in 1986 by Kun Shan Lu (K.S. Lu), who continues to serve as Chairman and Chief Executive Officer, providing over four decades of industry expertise in computer graphics and systems integration. In December 2024, the leadership team was strengthened by the appointment of Jerry Liang as President, who brought a background from Ableplus Precision Industry to oversee operational governance and market expansion into Southeast Asia. Other key executives include Richard Chou, General Manager of the Computer Business Unit, and Zhang Shen, Deputy General Manager of Finance. The board is composed of seasoned industry veterans including Ching-Ming Huang and representatives from strategic investment entities, while the company’s institutional investor base includes major regional index funds such as the CSI Small Cap 500, reflecting its established presence on the Taiwan Stock Exchange.